Brazil Cannabidiol Market Size & Outlook, 2024-2030
- Cannabis
- Cannabidiol & Cannabinoids
- Cannabidiol Market Outlook
- Cannabidiol & Cannabinoids
Global Market
Related Markets
Ask Prism AI anything about the cannabidiol market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Brazil cannabidiol market highlights
- The Brazil cannabidiol market generated a revenue of USD 18.0 million in 2024 and is expected to reach USD 41.3 million by 2030.
- The Brazil market is expected to grow at a CAGR of 14.8% from 2025 to 2030.
- In terms of segment, hemp was the largest revenue generating product in 2024.
- Hemp is the most lucrative product segment registering the fastest growth during the forecast period.
Cannabidiol market data book summary
| Market revenue in 2024 | USD 18.0 million |
| Market revenue in 2030 | USD 41.3 million |
| Growth rate | 14.8% (CAGR from 2025 to 2030) |
| Largest segment | Hemp |
| Fastest growing segment | Hemp |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hemp, Marijuana |
| Key market players worldwide | Medical Marijuana Inc, Canopy Growth Corp, Elixinol Wellness Ltd Ordinary Shares, The Cronos Group, Isodiol International Inc, Endoca, Folium Biosciences, NuLeaf Naturals, PharmaHemp |
Other key industry trends
- In terms of revenue, Brazil accounted for 0.2% of the global cannabidiol market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Mexico cannabidiol market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 91.4 million by 2030.
The Brazilian cannabis market is rapidly expanding, despite the lack of regulation, due to the emergence of numerous startups catering to different industry affairs. The market's potential is vast, with Brazil having one of the world's largest consumer markets and a population set to reach 215 million by the end of 2022. Although medical cannabis use among Brazilians is currently low, at approximately 41,000 individuals, it is expected to grow substantially.
Prohibition Partners' LATAMReport 2022 reveals that medical cannabis imports into Brazil rose by 39% in 2021, with the remainder being supplied by domestic producers. Brazil has legalized the use of Medicinal CBD oil since 2015 resulting in increasing demand for the product. The country is one of the top importers of CBD oil. Medical marijuana patients in Brazil must apply for ANVISA for individual permits, which have a maximum validity of a year but can be renewed.
However, the use of CBD for recreational purposes is still illegal in the country. Medical Marijuana, Inc. offers CBD-based medical products through its subsidiary Hemp Meds Brazil. The product has been approved by the Brazilian government for the treatment of cancer. The country has previously approved the CBD product, called Real Scientific Hemp Oil (RSHO), for the treatment of chronic pain, epilepsy, and Parkinson’s disease as a prescription medication.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cannabidiol Market Scope
Cannabidiol Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Canopy Growth Corp | View profile | 1,621 | 1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8 | www.canopygrowth.com |
| The Cronos Group | View profile | 1001-5000 | Kontich, Antwerpen, Belgium, Europe | cronos-groep.be/ |
| Medical Marijuana Inc | View profile | 85 | 2384 La Mirada Drive, Vista, CA, United States, 92081 | www.medicalmarijuanainc.com |
| Elixinol Wellness Ltd Ordinary Shares | View profile | - | 680 George Street, Level 12, Sydney, NSW, Australia, 2000 | www.elixinolwellness.com |
| Isodiol International Inc | View profile | 197 | 200 Granville Street, Suite 2710, Vancouver, BC, Canada, V6C 1S4 | www.isodiol.com |
| Endoca | View profile | 1-10 | Hoofddorp, Noord-Holland, The Netherlands, Europe | www.endoca.com/pl |
| Folium Biosciences | View profile | 101-250 | Colorado Springs, Colorado, United States, North America | foliumbiosciences.com/ |
| NuLeaf Naturals | View profile | 51-100 | Denver, Colorado, United States, North America | nuleafnaturals.com/ |
| PharmaHemp | View profile | 51-100 | Ljubljana, Ljubljana Urban Commune, Slovenia, Europe | b2b.pharma-hemp.com |
Brazil Cannabidiol Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cannabidiol Market Outlook will help companies and investors design strategic landscapes.
Hemp was the largest segment with a revenue share of 78.33% in 2024.
Horizon Databook has segmented the Brazil cannabidiol market based on hemp, marijuana covering the revenue growth of each sub-segment from 2018 to 2030.
The Brazilian cannabis market is rapidly expanding, despite the lack of regulation, due to the emergence of numerous startups catering to different industry affairs. The market's potential is vast, with Brazil having one of the world's largest consumer markets and a population set to reach 215 million by the end of 2022. Although medical cannabis use among Brazilians is currently low, at approximately 41,000 individuals, it is expected to grow substantially.
Prohibition Partners' LATAMReport 2022 reveals that medical cannabis imports into Brazil rose by 39% in 2021, with the remainder being supplied by domestic producers. Brazil has legalized the use of Medicinal CBD oil since 2015 resulting in increasing demand for the product. The country is one of the top importers of CBD oil. Medical marijuana patients in Brazil must apply for ANVISA for individual permits, which have a maximum validity of a year but can be renewed.
However, the use of CBD for recreational purposes is still illegal in the country. Medical Marijuana, Inc. offers CBD-based medical products through its subsidiary Hemp Meds Brazil. The product has been approved by the Brazilian government for the treatment of cancer. The country has previously approved the CBD product, called Real Scientific Hemp Oil (RSHO), for the treatment of chronic pain, epilepsy, and Parkinson’s disease as a prescription medication.
- Brazil Cannabidiol Market Product Outlook (Revenue, USD Million , 2018-2030)
- Hemp
- Marijuana
- Brazil Cannabidiol Market Sale Type Outlook (Revenue, USD Million , 2018-2030)
- B2B
- B2C
Reasons to subscribe to Cannabidiol Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cannabidiol Market Outlook databook
- Our clientele includes a mix of Cannabidiol Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil Cannabidiol Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Brazil Cannabidiol Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Brazil Cannabidiol Market, 2018-2030 (US$M)
Brazil cannabidiol market statistics, by product, 2018-2030 (US$M)
